Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Soligenix Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Oct 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for SNGXD

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Oct 2016 ValuEngine, Inc. 11 $25.00

"The Economy Matters" Report for SNGXD: the economy's impact on SNGXD's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

25 Oct 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review Summary Soligenix, Inc. (Soligenix) is a late-stage bio...

04 Oct 2016 GlobalData 72 $300.00

ValuEngine Rating and Forecast Report for SNGX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

02 Oct 2016 ValuEngine, Inc. 11 $25.00

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review Summary Soligenix, Inc. (Soligenix) is a late-stage bio...

19 Sep 2016 GlobalData 73 $300.00

Wright Investors Service Comprehensive Report for Soligenix, Incorporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Sep 2016 Wright Reports 65 $75.00

Soligenix's Diversified Pipeline Advances on All Fronts

The late-stage biopharmaceutical company Soligenix has had a string of good news. Revenue is up, the FDA awarded orphan statu...

31 Aug 2016 Streetwise Reports 3 $12.00

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review Summary Soligenix, Inc. (Soligenix) is a late-stage bio...

09 Jun 2016 GlobalData 73 $300.00

Soligenix Fosters Potent Pipeline of Orphan Disease Compounds in Areas of Unmet Medical Need

With a robust pipeline of drugs in late-stage clinical trials and milestones on the horizon, it's no wonder Soligenix Inc.'s ...

27 Apr 2016 Streetwise Reports 7 $69.00